Omnibus appropriations
This article was originally published in The Gray Sheet
Executive Summary
Senate may reconvene in December to consider seven-bill spending package, which would dole out $209.4 mil. for CDRH in agriculture appropriations conference report provision. The House is scheduled to consider the legislation when it reconvenes during the week of Dec. 8; Senate options include funding FDA at FY 2003 levels under a continuing resolution through Jan. 31, 2004, or unanimous consent passage before year-end. The amount closely aligns with the Senate bill, passed Nov. 6 (1"The Gray Sheet" Nov. 10, 2003, In Brief)...
You may also be interested in...
Congress backs CDRH raise
Senate votes 93-1 to spend $209.3 mil. for device center in FY 2004 agriculture approps bill Nov. 6, including $29.2 mil. in user fees. The House-cleared report offers $193.5 mil. in CDRH budget authority, while the Senate report originally proposed $191.9 mil. (1"The Gray Sheet" Nov. 3, 2003, p. 5). In its request to reconcile the amounts, the Senate appointed 17 conferees...
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.